CD19 and immunodeficiency disease: Antoli et al. [59] evaluated 70 patients with primary and secondary immunodeficiencies, including 31 patients with CVID, and demonstrated an impaired antibody response (29%), low CD19+ peripheral B cells, and low switched memory B cells.